UNSPSC 85642142: Revision of synthetic substitute in lower extremity subcutaneous tissue and fascia, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of synthetic substitute in lower extremity subcutaneous tissue and fascia, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JWW3JZ

UNSPSC 85642142 "Revision of synthetic substitute in lower extremity subcutaneous tissue and fascia, percutaneous approach" is a Commodity code that shows a substantial mismatch between its nominal clinical scope and the recent state and local procurement activity tagged to it. The six recent opportunities on file—independent medical evaluation services for pension disability determinations, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty healthcare for youth in custody, pharmacy benefit management, and temporary health professional staffing—span health plan administration, occupational health compliance, and staffing brokerage but do not involve orthopedic surgical procedures, synthetic grafts, or subcutaneous tissue revision. The code appears to be a classification error in the solicitation metadata rather than a meaningful procurement category. No recent state and local opportunities under this code involve the surgical product or service described in its name.

State and local issuing bodies posting opportunities under this code include county health systems, county board of commissioners offices, state transportation departments, city retirement offices, and county juvenile probation departments across Arizona, California, Florida, and Washington. Recent activity shows no pattern of repeat buyers or geographic concentration. Given the absence of procurement activity aligned with the code's stated clinical scope, this code presents no actionable opportunities for firms supplying surgical implants, tissue substitutes, or related orthopedic procedure support.